The U.S. 503B Compounding Pharmacies Market is estimated to be valued at US$ 87.52 Mn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031. https://www.coherentmarketinsights.com/market-insight/us-503b-compounding-pharmacies-market-4481